Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada

Saved in:

Bibliographic Details
Main Authors:	Gerth, William C, Betschel, Stephen D, Zbrozek, Arthur S
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2014
Subjects:	Meeting Abstract
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4125998/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-S1-A42
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items